ArticleOncotarget2019

Correction: A novel PI3K inhibitor PIK-C98 displays potent preclinical activity against multiple myeloma.

Jingyu Zhu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.